Cargando…

Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program

BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in...

Descripción completa

Detalles Bibliográficos
Autores principales: Makuza, Jean Damascene, Liu, Carol Y., Ntihabose, Corneille Killy, Dushimiyimana, Donatha, Umuraza, Sabine, Nisingizwe, Marie Paul, Umutesi, Justine, Serumondo, Janvier, Mugeni, Soline Dusabeyesu, Semakula, Muhamed, Gupta, Neil, Hellard, Margaret, Nsanzimana, Sabin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683524/
https://www.ncbi.nlm.nih.gov/pubmed/31382901
http://dx.doi.org/10.1186/s12879-019-4322-7
_version_ 1783442111825182720
author Makuza, Jean Damascene
Liu, Carol Y.
Ntihabose, Corneille Killy
Dushimiyimana, Donatha
Umuraza, Sabine
Nisingizwe, Marie Paul
Umutesi, Justine
Serumondo, Janvier
Mugeni, Soline Dusabeyesu
Semakula, Muhamed
Gupta, Neil
Hellard, Margaret
Nsanzimana, Sabin
author_facet Makuza, Jean Damascene
Liu, Carol Y.
Ntihabose, Corneille Killy
Dushimiyimana, Donatha
Umuraza, Sabine
Nisingizwe, Marie Paul
Umutesi, Justine
Serumondo, Janvier
Mugeni, Soline Dusabeyesu
Semakula, Muhamed
Gupta, Neil
Hellard, Margaret
Nsanzimana, Sabin
author_sort Makuza, Jean Damascene
collection PubMed
description BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in 24 districts previously identified to have a high HCV disease burden. At the time of sample collection, sociodemographic information and self-reported risk factors were collected. Bivariate and multivariate logistic regressions were conducted to assess risk factors independently associated with hepatitis C antibodies (HCVAb) seroprevalence. RESULTS: Out of a total of 326,263 individuals screened for HCVAb, 22,183 (6.8%) were positive. In multivariate analysis, risk factors identified as statistically associated with HCVAb Seroprevalence include history of traditional operation or scarification (OR = 1.09, 95% CI: 1.05–1.14), presence of viral hepatitis in the family (OR = 1.27, 95% CI: 1.15–1.40), widowed or separated/divorced (OR = 1.36, 95% CI: 1.26–1.47), Southern province (OR = 1.98, 95% CI: 1.88–2.08) and aged 65 years and older (OR = 4.86, 95% CI: 4.62–5.11). Ubudehe category 3 (OR = 0.97, 95% CI: 0.93–1.01) and participants using RAMA (Health insurances for employees of public and private sectors) insurance (OR = 0.76, 95% CI: 0.70–0.85) had lower odds of HCV seroprevalence. CONCLUSIONS: Our findings provide important information for Rwanda’s strategy on prevention and case-finding. Future prevention interventions should aim to reduce transmission through targeted messaging around traditional healing practices and case-finding targeting individuals with a history of exposure or advanced age.
format Online
Article
Text
id pubmed-6683524
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66835242019-08-09 Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program Makuza, Jean Damascene Liu, Carol Y. Ntihabose, Corneille Killy Dushimiyimana, Donatha Umuraza, Sabine Nisingizwe, Marie Paul Umutesi, Justine Serumondo, Janvier Mugeni, Soline Dusabeyesu Semakula, Muhamed Gupta, Neil Hellard, Margaret Nsanzimana, Sabin BMC Infect Dis Research Article BACKGROUND: The epidemiology and risk factors for hepatitis C virus (HCV) infection in Rwanda are not well known; however, this information is crucial to shaping the country’s public health approach to hepatitis C control. METHODS: A HCV screening campaign was conducted in the general population in 24 districts previously identified to have a high HCV disease burden. At the time of sample collection, sociodemographic information and self-reported risk factors were collected. Bivariate and multivariate logistic regressions were conducted to assess risk factors independently associated with hepatitis C antibodies (HCVAb) seroprevalence. RESULTS: Out of a total of 326,263 individuals screened for HCVAb, 22,183 (6.8%) were positive. In multivariate analysis, risk factors identified as statistically associated with HCVAb Seroprevalence include history of traditional operation or scarification (OR = 1.09, 95% CI: 1.05–1.14), presence of viral hepatitis in the family (OR = 1.27, 95% CI: 1.15–1.40), widowed or separated/divorced (OR = 1.36, 95% CI: 1.26–1.47), Southern province (OR = 1.98, 95% CI: 1.88–2.08) and aged 65 years and older (OR = 4.86, 95% CI: 4.62–5.11). Ubudehe category 3 (OR = 0.97, 95% CI: 0.93–1.01) and participants using RAMA (Health insurances for employees of public and private sectors) insurance (OR = 0.76, 95% CI: 0.70–0.85) had lower odds of HCV seroprevalence. CONCLUSIONS: Our findings provide important information for Rwanda’s strategy on prevention and case-finding. Future prevention interventions should aim to reduce transmission through targeted messaging around traditional healing practices and case-finding targeting individuals with a history of exposure or advanced age. BioMed Central 2019-08-05 /pmc/articles/PMC6683524/ /pubmed/31382901 http://dx.doi.org/10.1186/s12879-019-4322-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Makuza, Jean Damascene
Liu, Carol Y.
Ntihabose, Corneille Killy
Dushimiyimana, Donatha
Umuraza, Sabine
Nisingizwe, Marie Paul
Umutesi, Justine
Serumondo, Janvier
Mugeni, Soline Dusabeyesu
Semakula, Muhamed
Gupta, Neil
Hellard, Margaret
Nsanzimana, Sabin
Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title_full Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title_fullStr Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title_full_unstemmed Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title_short Risk factors for viral hepatitis C infection in Rwanda: results from a nationwide screening program
title_sort risk factors for viral hepatitis c infection in rwanda: results from a nationwide screening program
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683524/
https://www.ncbi.nlm.nih.gov/pubmed/31382901
http://dx.doi.org/10.1186/s12879-019-4322-7
work_keys_str_mv AT makuzajeandamascene riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT liucaroly riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT ntihabosecorneillekilly riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT dushimiyimanadonatha riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT umurazasabine riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT nisingizwemariepaul riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT umutesijustine riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT serumondojanvier riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT mugenisolinedusabeyesu riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT semakulamuhamed riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT guptaneil riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT hellardmargaret riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram
AT nsanzimanasabin riskfactorsforviralhepatitiscinfectioninrwandaresultsfromanationwidescreeningprogram